Advertisement

Prostate Cancer | Tumor

CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.

Radium-223 Safe and Effective to Treat Metastatic Castration-Resistant Prostate Cancer

June 3rd 2023

Treating patients with metastatic castration-resistant prostate cancer with radium-223 also allowed patients to receive subsequent therapies such as chemotherapy.

Lynparza Receives FDA Approval With Abiraterone for Treatment of Specific Patients With Prostate Cancer

May 31st 2023

Lynparza plus abiraterone was approved by the FDA for the treatment of patients with deleterious or suspected BRCA-mutated metastatic castration-resistant prostate cancer.

FDA Approves Imaging Agent for PSMA-Positive Lesions in Prostate Cancer With Suspected Metastasis

May 30th 2023

The approval of Posluma will help clinicians determine the extent of disease in men with prostate cancer and possible management options.

The Cancer Waiting Game

May 9th 2023

My husband is "that guy" who always takes care of everyone else, so his recent cancer scare was unfathomable.

Prostate Cancer Surveillance Is Safe With Continued Monitoring

May 8th 2023

Men with low-risk prostate cancer can usually safely forego treatment as long as they continue to monitor their disease with their clinicians, an expert said.

Fighting Cancer One Joke at a Time

May 2nd 2023

Finding humor in cancer has helped me cope.

Erleada Has ‘Robust Real-World Effectiveness’ in Prostate Cancer

May 2nd 2023

Erleada showed promising results in patients with metastatic castration-sensitive prostate cancer when compared with Xtandi and Zytiga.

For Smaller Men With Prostate Cancer, Erleada Dose Reduction May Decrease Skin-Related Side Effects

May 2nd 2023

A dose reduction of Erleada may result in fewer skin-related side effects for men with advanced prostate cancer — but only for those with a smaller body size, research showed.

Adding Nubeqa to Therapy May Reduce PSA Levels in Metastatic Hormone-Sensitive Prostate Cancer

May 1st 2023

Men with metastatic hormone-sensitive prostate cancer treated with Nubeqa, androgen-deprivation therapy and docetaxel had reductions in PSA levels that were associated with improved overall survival and a prolonged time to PSA progression.

Long-Term Nubeqa Is Safe, Efficacious in Prostate Cancer Treatment

May 1st 2023

Extended-duration Nubeqa reduced the risk of death in patients with nonmetastatic castration-resistant prostate cancer, study results showed.

PSMA-Targeted Therapy May Decrease PSA Levels in Metastatic Prostate Cancer Subset

May 1st 2023

Patients with metastatic castration-resistant prostate cancer treated with radioligand therapy, a form of targeted therapy, had improvements in PSA levels and survival with favorable side effect profiles.

Talk Show Host Jerry Springer Dies of Pancreatic Cancer, Pharma Company to Tackle Prostate Cancer Drug Shortage and More

April 28th 2023

From talk show host Jerry Springer’s death to “The Young and the Restless” star announcing a cancer diagnosis, here is what’s happening in the oncology space this week.

FDA Grants Fast Track Designation to New Prostate Cancer Treatment

April 24th 2023

The makers of a new treatment for metastatic, castration-resistant prostate cancer are working to bring it to patients “as quickly as possible.”

‘Pokémon’ Cast Member to Retire for Cancer Treatment, Musicians Die of Cancer and More

April 21st 2023

From ‘Pokémon’ actor James Carter Cathcart stepping away from the show to undergo cancer treatment to Ahmad Jamal and Otis Redding III dying of cancer, here’s what’s happening in the oncology space this week.

Prostate Cancer Drug Shortage: What Patients Need to Know

April 5th 2023

A prostate cancer expert lends insight to the nationwide Pluvicto shortage, and what eligible patients can do.

Long-Term Prostate Cancer Outcomes May Not Differ by Treatment Type

April 4th 2023

Researchers determined that mortality rates did not differ in men with localized prostate cancer if they underwent active monitoring, prostatectomy or radiotherapy.

MLB Coach Misses Opening Day for Cancer Surgery, WWE Star Warns Against Tanning

March 31st 2023

From the San Diego Padres’ coach missing Opening Day for colon cancer surgery to WWE star Alexa Bliss sharing her skin cancer experience and warning people against tanning beds, here’s what’s happening in the oncology space this week.

Nubeqa Plus ADT to Be Studied in Prostate Cancer Subset

March 29th 2023

The phase 3 ARASTEP trial will investigate Nubeqa plus androgen-deprivation therapy in certain patients with hormone-sensitive prostate cancer.

Gay and Bisexual Men With Prostate Cancer Have Unique Needs

March 24th 2023

Gay and bisexual men with prostate cancer may have different needs that need to be addressed with health care providers as they go through treatment and beyond.

My Social Media Algorithm Keeps Showing Cancer Content

March 21st 2023

Since I’ve become a patient and advocate, my social media algorithm now mostly shows cancer-related content. Here’s an open letter to said algorithm, or as I call it, “Algo.”

An Expert Discusses Nubeqa Side Effects Patients Should Know About

March 2nd 2023

Long-term follow-up of Nubeqa for nonmetastatic castration-resistant prostate cancer showed that the drug was safe and effective in treating this patient population.

Keytruda Misses Outcomes in Two Clinical Trials

March 1st 2023

One of the trials investigating Keytruda has been discontinued because the drug did not significantly improve outcomes in patients with prostate cancer.

Prostate Cancer Is No Joking Matter

February 27th 2023

With a wink and wearing a mischievous smile, my friend “Charley” likes to relate how he learned about his diagnosis of prostate cancer several years ago.

Chris Tucker Urges Black Men to Know Cancer Risk, Peloton Instructor Sees Mindset as a ‘Superpower’ During Cancer Treatment and More

February 24th 2023

From comedian Chris Tucker teaming up with a nonprofit to educate Black men on their prostate cancer risk to Leeane Hainby and Rep. Jamie Raskin providing updates on their cancer treatment, here’s what’s happening in the cancer space this week.

What to Expect During Genomic Testing for Prostate Cancer

February 22nd 2023

An expert explains what patients with low-grade prostate cancer can expect when undergoing genomic testing — and why the procedure is important.

Nubeqa, ADT Combo Should Be New Standard of Care for Some Patients With Prostate Cancer

February 18th 2023

The combination demonstrated survival benefit in patients with metastatic hormone-sensitive prostate cancer, regardless of risk or volume of disease.

Senator Undergoes Prostate Cancer Surgery, Man Gives His Super Bowl Tickets to a Friend With Cancer and More

February 17th 2023

From Senator Bob Casey undergoing prostate cancer surgery to a man giving away his Superbowl tickets to a good friend with stage 4 cancer, here’s what is happening in the oncology space this week.

Treatment With Pluvicto Soon After Radium-223 Is Safe, Effective for Prostate Cancer

February 17th 2023

The administration of Pluvicto within six months of radium-223 treatment proved to be safe and efficacious in patients with metastatic castration-resistant prostate cancer, research showed.

Nubeqa Outperforms Xtandi, Erleada in Non-metastatic Castration-resistant Prostate Cancer

February 16th 2023

Patients treated with Nubeqa were less likely to develop disease metastasis or discontinue treatment 6 to 18 months after ARI course start compared to Xtandi or Erleada, according to data presented at ASCO GU.

Blood Test May Predict Likelihood of Prostate Cancer Metastasis

February 15th 2023

Advertisement
Advertisement